Alveo is leading the transformation of the consumer and point-of-care health tech market with a low-cost, easy-to-use and accessible diagnostic platform that will change the way infectious diseases are detected and managed. The Company's be.well testing platform gives individuals access to cutting-edge molecular testing & cloud-based data analytics for rapid diagnosis and management of infectious diseases. With be.well, we will know sooner, act faster, and make better, more-informed decisions.